sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Tue Dec 16
Barclays Maintains Overweight Rating on Energy Transfer LP (ET)
20h
Y
Where is Vale S.A. (VALE) Headed According to Analysts?
20h
Y
This is What Analysts Are Saying About Cenovus Energy Inc. (CVE)
20h
Y
Where is JD.com (JD) Headed According to the Street?
20h
Y
Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30
20h
Y
2 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run
20h
Y
Here is What Analysts Think About AT&T Inc. (T)
20h
Y
Here’s What Analysts Think About Fortinet (FTNT)
20h
Y
What Do Analysts Think About KLA Corporation (KLAC)?
20h
Y
Where is Palantir Technologies Inc. (PLTR) Headed According to Analysts?
20h
Y
This is What Analysts Think About Arista Networks (ANET)
20h
Y
What Does Wall Street Think About ServiceNow (NOW)?
20h
Y
Where is Eli Lilly and Company (LLY) Headed According to Analysts?
20h
Y
Is Advanced Micro Devices (AMD) One of the Best Long Term Growth Stocks to Buy According to Hedge Funds?
20h
Y
This is What The Street Thinks About Uber Technologies (UBER)
20h
Y
Alphatec Holdings, Inc. (ATEC) Shares Preliminary 2025 Results and 2026 Outlook
20h
Y
Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)
20h
Y
Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why
20h
Y
Edgewise Therapeutics, Inc. (EWTX) Outlines Priorities For 2026
20h
Y
Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside
20h
Y
Vera Therapeutics, Inc. (VERA) Granted FDA Priority Review For Atacicept
20h
Y
Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral
20h
Y
Is Immunome, Inc. (IMNM) The Best Booming Stock To Buy Right Now?
20h
Y
Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus
20h
Y
Wall Street Bullish on Spyre Therapeutics, Inc. (SYRE) with Strong Buy Rating
20h
Y
Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib
20h
Y
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating
20h
Y
Analysts Project 120% Upside To Dyne Therapeutics, Inc. (DYN)
20h
Y
Senate Delays Clarity Act Meeting After Coinbase Opposition
20h
Y
Silver surge masks quiet risk
20h
Y
CME Group to Launch Cardano, Chainlink, Stellar Futures on Feb 9
20h
Y
European corporates expected to deliver worst earnings growth in past seven quarters
20h
Y
AI Is Rewriting Global Power Needs, Creating a Massive Opportunity for This Engineering and Construction Company
20h
Y
Bank of America resets IBM price target before earnings
21h
Y
Why Taiwan Semiconductor Stock Surged Today
21h
Y
Insteel (IIIN) Q1 2026 Earnings Call Transcript
21h
Y
First Horizon (FHN) Q4 2025 Earnings Transcript
21h
Y
ADTRAN Eyes 2026 Momentum at Needham Conference as Optical Demand, Europe Huawei Swap Accelerate
21h
Y
Trump Tariffs Will Clear The Supreme Court Hurdle? Crypto Bettors Say: No
21h
Y
Steven Cress' Top 10 Stocks For 2026
21h
S
Nepsis Bets on CAVA's Future Growth Plan With $2.9 Million Purchase
21h
Y
Worried About a Stock Market Crash in 2026? Avoid This 1 Common Investing Mistake.
21h
Y
If I Could Own Only 1 Quantum Computing Stock in 2026, This Would Be It
21h
Y
A Wealthy Connecticut Homeowner Asks If Anyone Regrets Moving To A Cheaper State? 'Absolutely. From SoCal To TX. Don't Recommend It'
21h
Y
Morgan Stanley beats consensus, defends keeping older goals
21h
Y
Rosenblatt reiterates buy on Bullish even as IPO unlock looms
21h
Y
Ocular Therapeutix Launches On Rumors Sanofi Is Preparing A Bigger Bid
21h
Y
Cogeco Q1 Earnings Call Highlights
21h
Y
Morgan Stanley Q4 Earnings Call Highlights
21h
Y
BlackRock Q4 Earnings Call Highlights
21h
Y
More →